The pursuit of therapeutic targets is further complicated by the intricate interplay between WNT signaling and other pathways essential for melanoma pathogenesis, notably MAPK/ERK and PI3K/AKT pathways [365, 366]. The gene discussed is MAPK1; the disease is melanoma.